Clarity in cell line development

Solentim appoints new sales manager for USA East

Solentim is pleased to announce the appointment of Jake Isaacs to the role of Sales Manager, USA East Coast. Jake is based in the Greater Boston area and holds a PhD in biochemistry/biophysics with postdoctoral training in immunology, cell biology and molecular diagnostics. He has a passion for cutting-edge technology and its application to outstanding …

Read more Solentim appoints new sales manager for USA East

Solentim and ATUM to bundle Leap-In Transposase® with the VIPS™ single cell cloning instrument for cell line development

Bournemouth, UK and Newark, CA, USA, 20th April 2020 / Solentim, a global leader in cell line development (CLD) instrumentation, and bioengineering company ATUM, today announced that Solentim will bundle access to the Leap-In Transposase® platform together with the Solentim VIPS™ single cell cloning instrument. Leap-In Transposases enable stable high titer clones to be isolated whilst screening …

Read more Solentim and ATUM to bundle Leap-In Transposase® with the VIPS™ single cell cloning instrument for cell line development

Duncan Borthwick joins Solentim as Global Marketing Manager

Solentim, the leader in cell line biopharmaceutical instruments, is pleased to announce that Dr Duncan Borthwick will join the Company as the new Global Marketing Manager. Duncan has a strong commercial background in bringing new technologies to international markets. With a PhD from Edinburgh University, his previous work experience includes life science distribution companies Cambridge …

Read more Duncan Borthwick joins Solentim as Global Marketing Manager

Translate »